Pentacel® Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed / Inactivated Poliovirus / Haemophilus b Conjugate (Tetanus Toxoid Conjugate) Vaccine, Preservative Free 15 Lf - 5 Lf - 20 mcg - 62 DU - 10 mcg / 0.5 mL Injection 0.5 mL

Features

• Pentacel is a vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b
• Pentacel vaccine is approved for use as a four dose series in children 6 weeks through 4 years of age (prior to 5th birthday)
• Each 0.5 mL dose contains 15 Lf diphtheria toxoid, 5 Lf tetanus toxoid, acellular pertussis antigens [20 mcg detoxified pertussis toxin (PT), 20 mcg filamentous hemagglutinin (FHA), 3 mcg pertactin (PRN), 5 mcg fimbriae types 2 and 3 (FIM)], inactivated polioviruses [40 D-antigen units (DU) Type 1 (Mahoney), 8 DU Type 2 (MEF-1), 32 DU Type 3 (Saukett)] and 10 mcg PRP of H influenzae type b covalently bound to 24 mcg of tetanus toxoid (PRP-T)
• 5 Dose Package containing 5 vials of DTaP-IPV component to be used to reconstitute five single dose vials of lyophilized ActHIB vaccine component
• Store Refrigerated at 2 to 8 degrees C (36 to 46 degrees F)
• WARNING: Cancer and Reproductive Harm - www.P65Warnings.ca.gov

More Information

• SDS